{"id":"W4402560083","doi":"10.1016/j.annonc.2024.08.691","title":"624P Belvarafenib in patients (pts) with BRAF class II or III alteration-positive tumours: TAPISTRY study","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022719,0.0004207037,0.0004189678,0.000275879,0.0003047879,0.0007018656,0.0002003271,0.0004434861,0.001845639],"category_scores_gemma":[0.0004898559,0.0003421804,0.0005663136,0.0004044489,0.0002353213,0.0005106666,0.000342266,0.0006148411,0.0005210911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002792525,"about_ca_system_score_gemma":0.0002136193,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007541224,"about_ca_topic_score_gemma":0.0008062752,"domain_scores_codex":[0.9998471,0.00002988294,0.00001010067,0.00005542117,0.00001964674,0.00003784917],"domain_scores_gemma":[0.9998306,0.00002149554,0.00005158376,0.00001290925,0.00001560575,0.00006771846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.03043506,0.001324252,0.9390186,0.0001156954,0.0006877705,0.001408947,0.0002316887,0.0002472152,0.01116979,0.000139175,0.0005132436,0.01470856],"study_design_scores_gemma":[0.001263662,0.008885134,0.9823673,0.00001603734,0.0008261784,0.002381341,0.0003415238,0.0006038983,0.0009659335,0.000199665,0.002127611,0.00002174667],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992566,0.0001737404,0.00005154047,0.00002248407,0.000006792882,0.00000939262,0.0001085449,0.000002223386,0.0003687155],"genre_scores_gemma":[0.9991226,0.0001043842,0.00004162218,0.00003731091,0.00001659234,0.00001042999,0.0002398741,0.000002174976,0.0004252523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001845639,"threshold_uncertainty_score":0.006174266,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02672696747127241,"score_gpt":0.3241200443127323,"score_spread":0.2973930768414599,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}